1/28
07:47 am
bctx
BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation [Yahoo! Finance]
Medium
Report
BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation [Yahoo! Finance]
1/28
07:30 am
bctx
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
Medium
Report
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
1/27
07:30 am
bctx
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
Low
Report
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
1/15
04:05 pm
bctx
BriaCell Therapeutics Announces Closing of US$30 million Public Offering
Medium
Report
BriaCell Therapeutics Announces Closing of US$30 million Public Offering
1/14
01:38 am
bctx
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit [Seeking Alpha]
High
Report
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit [Seeking Alpha]
1/13
09:00 pm
bctx
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
High
Report
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
1/7
10:32 am
bctx
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
Low
Report
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
12/18
07:42 am
bctx
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine [Yahoo! Finance]
Low
Report
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine [Yahoo! Finance]
12/18
07:30 am
bctx
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine
Low
Report
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine
12/10
07:30 am
bctx
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
High
Report
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
12/9
07:30 am
bctx
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
Medium
Report
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
12/2
07:30 am
bctx
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025
Medium
Report
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025
11/25
07:30 am
bctx
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
High
Report
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
11/20
07:30 am
bctx
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
Medium
Report
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
11/18
07:30 am
bctx
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025
Medium
Report
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025